Ainimo
Latest round
- Series A
Last raised
- Apr 2023
Total raised
- Undisclosed
Investors
- 2
About Ainimo
Based in Jiaxing, China and founded in 2022, Ainimo operates as a manufacturer of experimental large animals and innovative animal disease models, focusing on the production of experimental large animals and the development of innovative animal disease models. The company has obtained a laboratory animal production license and a laboratory animal use license. Ainimo has established a laboratory animal production base in the eastern suburbs of Nanjing. The company is committed to pioneering innovative animal disease models and has nearly 700 Beagle breeders and has completed the development and application of over 20 animal models. Ainimo's animal disease models cover a wide range of areas including cardiovascular, central nervous system, oncology, metabolic, ophthalmic, autoimmune and liver and kidney diseases.
Who invested in Ainimo
2 investors across 1 round
See all investors in Ainimo
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 26, 2023
Amount
Undisclosed
Investors
Questions about Ainimo
Who invested in Ainimo?
Ainimo has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ainimo raised?
Ainimo has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ainimo last raise money?
Ainimo's most recent round on record is a Series A, in Apr 2023.
What does Ainimo do?
Based in Jiaxing, China and founded in 2022, Ainimo operates as a manufacturer of experimental large animals and innovative animal disease models, focusing on the production of experimental large animals and the development of innovative animal disease models.
Where is Ainimo headquartered?
Ainimo is headquartered in Jiaxing, China.
Which VCs invest in companies like Ainimo?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Ainimo's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ainimo? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.